PALTC23 Conference Recordings FR20 Enhancing Infection Control through Enhanced Barrier Precautions in Skilled Nursing Facilities

Enhancing Infection Control through Enhanced Barrier Precautions in Skilled Nursing Facilities

This session will review the CDC’s recommendations for the use of Enhanced Barrier Precautions in Skilled Nursing Facilities covering the 2019 interim guidance and 2021 White Paper expanding its use, and current state-of-the-art recommendations. The topics will cover epidemiology of MDRO infection and colonization in SNFs, proposed transmission of MDROs, defining EBP procedures and indications, the evidence base supporting EBP, implementation approaches and barriers, cost considerations, and unresolved questions. The session will be framed around a case based discussion.

Learning Objectives:

At the completion of this session, learners will be able to:

  • Describe the burden on MDROs and the reasons for the disproportionately high risk of MDRO transmission in SNFs.
  • Define EBP and appropriate residents who would benefit from its use.
  • Develop a plan for EBP implementation in SNF.

Omid Salaami, MD

Omid Salaami, MD, is an Attending at Scripps Clinic Medical Group in San Diego, California where specializes in post-acute and long-term care medicine. He is a recent graduate in Geriatric Medicine from Duke University where he also completed an advanced fellowship focused in PALTC.


Kara Jacobs Slifka, MD, MPH

Kara Jacobs Slifka, MD, MPH, is an infectious diseases physician and medical epidemiologist in the Prevention and Response Branch within CDC’s Division of Healthcare Quality Promotion. In her role at CDC, she leads the long-term care team focused on improving infection prevention and containing and preventing the spread of infectious pathogens in the post-acute and long-term care settings through collaboration with health departments and partners, guidance and educational material development and outbreak response.

  • 1.0 CME
  • 1.0 CMD Management
  • 1.0 MOC

Release Date: 03/29/2023   |   Expiration: 03/01/2026

Credit Statements:

Accreditation: Post-Acute and Long-Term Care Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

CME Designation: Post-Acute and Long-Term Care Medical Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CMD Credit Hours: This CME activity has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for up to 1.0 management hour(s) toward certification or recertification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. Each physician should claim only those hours of credit actually spent on the activity.

The CMD Program is administered by the ABPLM. For further information, contact ABPLM at 410-992-3117 or at cmd@paltmed.org.

ABIM Maintenance of Certification (MOC): Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points and patient safety credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Financial Disclosure Statement:

The Association requires the disclosure of all speaker/faculty/planner’s relevant financial relationships; presence of off-label use of a device or medication; and discussion of any experimental, new or evolving topic prior to each accredited education activity.

If the learner perceives any bias toward a commercial product or service, advocation of unscientific approaches to diagnosis or therapy, or recommendation, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients please report this to the Association's staff.


The following speaker(s) disclosed relevant financial relationship(s): 

  • Julie Gammack, MD, CMD (Planner & Speaker): Stockholder: Amarin
  • Kenya Rivas Velasquez, MD, CMD, FAAFP (Planner & Speaker): OptumRx: Stockholder
  • All other planners, speakers, and AMDA staff have no relationships with ineligible companies.

All relevant financial relationships have been identified and mitigated.

Components visible upon registration.